DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

D.h.e. 45 (Dihydroergotamine Mesylate) - Published Studies


D.h.e. 45 Related Published Studies

Well-designed clinical trials related to D.h.e. 45 (Dihydroergotamine)

Assessing acute systemic effects of an inhaled drug with serial echocardiography: a placebo-controlled comparison of inhaled and intravenous dihydroergotamine. [2013]

Effects of a supratherapeutic dose of investigational orally inhaled dihydroergotamine (MAP0004) on QT interval: a randomized, double-blind, active- and placebo-controlled crossover study in healthy volunteers. [2012]

The PROMISE study: PROphylaxis of MIgraine with SEglor (dihydroergotamine mesilate) in French primary care. [2004]

Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. [2001.11]

Haemodynamic effects of three doses of dihydroergotamine during spinal anaesthesia. [2001.09]

Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data. [2001.07]

Effects of dihydroergotamine on intracranial pressure, cerebral blood flow, and cerebral metabolism in patients undergoing craniotomy for brain tumors. [2001.07]

A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine. [2000.06]

Bioavailability of intranasal formulations of dihydroergotamine. [1999.11]

Dihydroergotamine nasal spray in the treatment of acute migraine. [1998.09]

Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache. [1998.08]

Oral dihydroergotamine for therapy-resistant migraine attacks in children. [1997.02]

A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine. [1996.08]

Comparing dihydroergotamine mesylate and sumatriptan in the management of acute migraine. A retrospective cost-efficacy analysis. [1996.07]

A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement. [1996.02]

A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. [1996.02]

The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination. [1996]

[Calcium carbasalate-metoclopramide combination versus dihydroergotamine in the treatment of migraine attacks] [1995.11]

Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine. [1995.05]

Studies on the effect of short-term oral dihydroergotamine and troxerutin in patients with varicose veins. [1994.10]

Dihydroergotamine nasal spray for the acute treatment of migraine. [1994.03]

[Treatment of migraine attacks: combination of dihydroergotamine tartrate and paracetamol in comparison with individual drugs and placebo] [1993.11.15]

Subcutaneous sumatriptan in the acute treatment of migraine in patients using dihydroergotamine as prophylaxis. French Migraine Network Bordeaux-Lyon-Grenoble. [1993.09]

Effect of dihydroergotamine on leg blood flow during combined epidural and general anaesthesia and postoperative deep vein thrombosis after cholecystectomy. [1993.04]

Lipolytic effect of low-molecular-weight-heparin (Fragmin) and heparin/dihydroergotamine in thromboprophylactic doses during total hip replacement. [1992.11]

Apparent lack of synergism between heparin and dihydroergotamine in prevention of deep vein thrombosis after elective hip replacement: a randomised double-blind trial reported in conjunction with an overview of previous results. [1992.09.07]

Thromboembolic prophylaxis in total hip replacement: a comparison between the low molecular weight heparinoid Lomoparan and heparin-dihydroergotamine. [1992.09]

Dihydroergokryptine versus dihydroergotamine in migraine prophylaxis: a double-blind clinical trial. [1991.07]

A prospective comparison of thromboembolic stockings, external sequential pneumatic compression stockings and heparin sodium/dihydroergotamine mesylate for the prevention of thromboembolic complications in urological surgery. [1991.06]

Pharmacokinetic investigation of oral and i.v. dihydroergotamine in healthy subjects. [1991]

[Flunarizine and dihydroergotamine in the treatment of migraine in children] [1990.03]

Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis. [1989.04]

Effects of dihydroergotamine on psychomotor function, neuroendocrine parameters and blood pressure, in healthy volunteers. [1989.01]

Prevention of thromboembolism in hip-fracture patients. Comparison of low-dose heparin and low-molecular-weight heparin combined with dihydroergotamine. [1989]

Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery. [1988.07]

Dihydroergotamine and the thromboprophylactic effect of dextran 70 in emergency hip surgery. [1988.04]

[Thrombosis prevention with heparin/dihydroergotamine versus heparin/Sintrom in Ender nailing of pertrochanteric fractures] [1988.02]

Well-designed clinical trials possibly related to D.h.e. 45 (Dihydroergotamine)

Reduced efficacy of sumatriptan in migraine with aura vs without aura. [2015]

Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults. [2012]

Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia. [2012]

A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine. [2009.06]

Symptomatic treatment of migraine in children: a systematic review of medication trials. [2005.08]

Randomized clinical trials of neurally mediated syncope. [2003.09]

Incidence and time course of cardiovascular side effects during spinal anesthesia after prophylactic administration of intravenous fluids or vasoconstrictors. [1998.08]

[Treatment of acute attack of migraine with sumatriptan] [1997.11]

[Treatment of acute migraine attacks] [1995.01]

[Increased wound healing disorders in patients with inguinal hernia caused by administration of antithrombotic agents in the abdominal wall] [1994.08]

Low doses of heparin and heparin dihydergot in postoperative thromboprophylaxis in gynaecological patients. [1994.07]

Current emergency treatment of severe migraine headaches. [1993.11]

[Ropivacaine 1% versus bupivacaine 0.75% without a vasoconstrictor. A comparative study of epidural anesthesia in orthopedic surgery] [1993.09]

Prevention of postoperative thromboembolism in gynaecological malignancy. [1993]

A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. [1992.08.01]

Cardiovascular parameters and catecholamines in volunteers during passive orthostasis. Influence of antihypotensive drugs. [1992.05]

[Propofol for sedation during postoperative mechanical ventilation. A comparative study with Lytic Mixture] [1992]

Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen. [1992]

[Quality requirements in clinical studies in surgery exemplified by prevention of thromboembolism] [1991]

[Different effectiveness of two preparations of low molecular weight heparin in patients with elective hip joint replacement] [1991]

A comparative trial of three agents in the treatment of acute migraine headache. [1990.10]

Superficial hand and foot veins show no difference in sensitivity to constrictor agents. [1990.07]

[Prevention of thromboembolism in para-articular femoral fractures of the hip--results of a prospective randomized study of heparin-DHE and ASS-DHE] [1990.06]

[Perioperative prevention of thromboembolism with low molecular weight heparin and postoperative bleeding complications] [1990]

Operative venodilation: a previously unsuspected factor in the cause of postoperative deep vein thrombosis. [1989.08]

A prospective randomized trial of low molecular weight heparin-DHE and conventional heparin-DHE (with acenocoumarol) in patients undergoing gynaecological surgery. [1989]

[Prevention of thromboembolism in hysterectomies with low molecular weight heparin Fragmin] [1988.03]

Other research related to D.h.e. 45 (Dihydroergotamine)

MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments. [2011.10]

Where is dihydroergotamine mesylate in the changing landscape of migraine therapy? [2010.12]

Outpatient home-based continuous intravenous dihydroergotamine therapy for intractable migraine. [2010.05]

Dihydroergotamine: role in the treatment of migraine. [2009.09]

Inpatient treatment of status migraine with dihydroergotamine in children and adolescents. [2009.01]

History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward. [2008.08]

Intrapulmonary and intravenous administrations of dihydroergotamine mesylate have similar cardiovascular effects in the conscious dog. [2008.07]

Safety and pharmacokinetics of dihydroergotamine mesylate administered via a Novel (Tempo) inhaler. [2008.03]

Dihydroergotamine for early and late treatment of migraine with cutaneous allodynia: an open-label pilot trial. [2007.06]

Contractile responses to ergotamine and dihydroergotamine in the perfused middle cerebral artery of rat. [2007.04]

Dihydroergotamine nasal spray for relief of refractory headache: a retrospective chart review. [2007.04]

Repetitive dihydroergotamine nasal spray for treatment of refractory headaches: an open-label pilot study. [2006.10]

Other possibly related research studies

The Relative Efficacy of Meperidine for the Treatment of Acute Migraine: A Meta-analysis of Randomized Controlled Trials. [2008.07.14]

Randomized, double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of MAP0004 (orally-inhaled DHE) in adult asthmatics. [2008.07]

Tactile-induced ultrasonic vocalization in the rat: a novel assay to assess anti-migraine therapies in vivo. [2008.07]

Treatment of children with migraine in the emergency department: a qualitative systematic review. [2008.05]

Triptans: actions and reactions. [2008.04]

Pharmacological properties of a wide array of ergolines at functional alpha(1)-adrenoceptor subtypes. [2008.01]

Acute treatment of paediatric migraine: A meta-analysis of efficacy. [2008.01]

Olcegepant, a non-peptide CGRP1 antagonist for migraine treatment. [2007.08]

Emergency department management of acute migraine in children in Canada: a practice variation study. [2007.05]

Serotonin enhances beta-endorphin secretion to lower plasma glucose in streptozotocin-induced diabetic rats. [2007.04.24]

Acute treatment for migraine headache. [2007.02]

DHE in the pharmacotherapy of migraine: potential for a larger role. [2006.11]

Nasal delivery of antimigraine drugs: clinical rationale and evidence base. [2006.11]

Central sensitization theory of migraine: clinical implications. [2006.11]

Cardiovascular excitatory effect on rats of a fraction isolated from the eyestalk of shrimp: Peneaus vanameii. [2006.06]

Diagnosis and treatment of cluster headache. [2006.04]

Acute therapy for migraine headaches. [2006.04]

Medications for migraine prophylaxis. [2006.01.01]

Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society. [2008.06]

Migraine, allodynia, and implications for treatment. [2008.12]

The relative efficacy of meperidine for the treatment of acute migraine: a meta-analysis of randomized controlled trials. [2008.12]

[Pathophysiology of migraine and clinical implications] [2008.10]

Pharmacological management of postoperative ileus. [2009.04]

Cluster attacks responsive to recreational cannabis and dronabinol. [2009.06]

Diagnosis and management of the primary headache disorders in the emergency department setting. [2009.02]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017